by NEWSNER , 2021-02-03 00:30:44
According to the info released by the Union Ministry of Health and Family Welfare on Tuesday, besides Arunachal Pradesh, four other states -- Odisha (99.13 per cent), Bihar (99.09 per cent), Mizoram (99.09 per cent) and Andhra Pradesh (99.05 per cent) -- have a recovery rate of above 99 per cent against the national average of 97.05 per cent.
According to the health officials, six other northeastern states - Nagaland (98.83 per cent), Tripura (98.78 per cent), Assam (98.66 per cent), Meghalaya (98.49 per cent), Manipur (98.25 per cent) and Sikkim (96.44 per cent) - also exceeded national recovery rate.
Another northeastern state Mizoram has earned the excellence of getting rock bottom death rate of 0.21 per cent among the 28 states in India while Punjab remained within the top position in Covid-19 moratality at 3.24 per cent against the national deathrate of 1.43 per cent.
Sikkim's deathrate of two .22 per cent is that the third highest within the country after Maharashtra's 2.52 per cent.
According to the Health and Family Welfare Ministry data, the deathrate in six other northeastern states - Manipur (1.28 per cent), Tripura (1.17 per cent), Meghalaya (1.06 per cent), Assam (0.50 per cent), Nagaland (0.73 per cent) and Arunachal Pradesh (0.33 per cent) - are less than the national average.
According to the officials of the Health and Family Welfare Department of Assam, the state had reported its first death thanks to coronavirus on April 10. the primary death in Assam, also as within the northeastern region, was reported from Hailakandi district in southern Assam where a man , who had visited abroad,
succumbed to Covid-19 at the Silchar Medical College and Hospital.
Mizoram was the lone state in India where there was no Covid-19 related death until October 28 last year when a 62-year-old man died of Covid-19 within the mountainous state whilst the primary death was reported in India on January 30, 2020.
The nationwide immunization drive began across the country on January 16 after the approval of two Covid vaccines -- Covishield and Covaxin, which are cleared for emergency use by the authorities.
Hyderabad-based Bharat Biotech is that the manufacturer of India's first indigenous vaccine for Covid-19 - Covaxin - while Covishield has been developed by Oxford University and drug company AstraZeneca and made by the Serum Institute of India in Pune.Over 39,50,000 people, mostly doctors, vaccinated thus far.